I et klinisk studie, der undersøgte den farmakodynamiske effekt af den anbefalede dosis af peptidet hos frivillige personer under oral GTT (Glukose Tolerance Test), observeredes ingen andre påvirkninger end det normale fysiologiske respons på oral glucosebelastning.
In a clinical study examining the pharmacodynamic effects of the recommended dose of the peptide in human volunteers during an oral GTT (Glucose Tolerance Test), no effects were observed other than the normal physiologic response to oral glucose challenge.